Best Peptide Stack for Cutting

Cutting without pharmacological support means fighting your body's survival mechanisms: increased hunger, metabolic adaptation, and muscle catabolism. Each of these can be specifically addressed with peptide stacking:

• Appetite suppression — GLP-1 agonists make sustained deficits tolerable
• Lipolysis enhancement — GH peptides mobilize stored fat preferentially over muscle protein
• Muscle preservation — IGF-1 elevation from GH peptides maintains protein synthesis during restriction
• Metabolic rate support — GH counteracts the metabolic slowdown that accompanies caloric deficit

The right stack makes cutting dramatically more effective and sustainable.

The ideal cutting stack emphasizes fat loss over muscle gain:

• Semaglutide (or Tirzepatide) — The appetite suppression anchor. Makes a 500–750 kcal deficit feel effortless. Tirzepatide may produce greater weight loss for some subjects.
• Ipamorelin — Selective GH secretagogue for lipolysis and muscle preservation. The clean GHRP with minimal side effects.
• Tesamorelin — GHRH analog specifically studied for visceral fat reduction. Targets the deep abdominal fat that's hardest to lose.

Optional: Add a low dose of BPC-157 if training intensity remains high during the cut to support recovery at a caloric deficit.

During a cut, higher semaglutide doses (1.0–2.4 mg) may be appropriate for stronger appetite control. Ipamorelin + tesamorelin administered pre-bed maximizes the nocturnal GH pulse for overnight fat oxidation. Maintain protein at 1.2g per lb of lean mass minimum.

Weeks 1–4: Appetite plummets. The caloric deficit becomes easy to sustain. Initial weight loss is a mix of fat and water. Expect 3–5 lbs total loss. Sleep quality improves from ipamorelin.

Weeks 4–8: Aggressive fat loss phase. Visible definition begins emerging—especially around the midsection as tesamorelin targets visceral fat. 6–10 lbs of fat loss typical. Muscle mass maintained or slightly increased.

Weeks 8–16: Dramatic transformation. Total fat loss of 12–20+ lbs depending on starting point. Vascularity and muscle definition significantly improved. Subjects who were 20%+ body fat can reach 12–15% in this window.

The aggressive caloric deficit combined with multiple compounds requires careful monitoring. Semaglutide GI effects (nausea, constipation) are most common during titration. GH peptides may cause water retention that temporarily masks fat loss on the scale.

Critical precautions: Don't crash-diet—even with appetite suppression, going below 1,200 kcal risks muscle loss and metabolic damage. Keep protein high. Electrolyte supplementation is important during aggressive cuts. Monitor blood glucose (GH + caloric restriction can cause hypoglycemia in sensitive individuals).

A cutting phase is time-sensitive—you don't want to waste 8–16 weeks on underdosed products. Ascension Peptides delivers verified quality:

• 99%+ purity semaglutide, ipamorelin, and tesamorelin
• Third-party tested with batch-specific COAs
• Reliable supply chain so you never have gaps in your protocol

Commit to your cut with confidence—source from Ascension Peptides.